Reported Jun 30, 2022
Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging…
Mohnark Pharmaceuticals Inc. of Davie, Fla.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
Firm contact: Mohnark Pharmaceuticals toll-free at 866-611-5206 from 9 a.m. to 4 p.m. ET Monday through Friday, or online at www.mohnark.com and click on "RECALL" at the top of the page for more information.
What it looks like
Is this the product you have?
- Lidocaine 4% Topical Anesthetic Cream
- UPCs
860002324906- Amount recalled
- About 9,000
Where it was sold
Sold at Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7..
Why it was recalled
The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
The agency has not ranked the risk yet — treat the notice as a caution.
Reports so far: None reported
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mohnark Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.

